FDA-Labeled Indications for Chronic Weight Management As of early 2026, two medications carry FDA indications specifically for chronic weight management in adults: Wegovy (semaglutide 2.4 mg) approved 2021 Zepbound (tirzepatide) approved 2023 Liraglutide (Saxenda) is also approved for weight management but has been largely supplanted by the once-weekly options
GLP-1s for Psoriatic Arthritis (PsA) Asthma One study of more than 3,000 adults who were overweight or had obesity found that those taking a GLP-1 had a 12 to 15 percent lower risk of asthma exacerbations than those not taking these drugs
Speak to your health provider about GLP-1 options
These include a products safety, effectiveness, cost, convenience, and in this case taste
It is whether we can lose the right weight
Benefits of Wegovy If you've been searching "who prescribes Wegovy near you" or "does Wegovy work for weight loss?" it's important to know the broader benefits beyond shedding pounds